Abstract
MIF, aproinflammatory cytokine, contributes to the pathogenesis of acute, chronic, and autoimmune inflammatory disorders and balances the suppressive effect of glucocorticoids on the immune system. There is an interaction between bone metabolism and the immune system via the production of cytokines. We aimed to analyze the relationship between the MIF gene -173G> C promoter polymorphism and osteoporosis. In this case-control study performed in auniversity hospital, 286 samples (136 women with osteoporosis and 150 healthy age-matched controls) participated. The polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) assay was used to genotype the MIF gene polymorphism. The alleles and genotypes frequencies of patients and controls were compared using the χ2 test. The genotype frequencies of MIF gene -173G> C polymorphism showed statistically significant differences between patients and controls (p= 0.038). Also, the subjects carrying the variantC allele in the MIF -173 position were at significantly higher risk of osteoporosis than subjects carrying the wild-typeG allele (p= 0.009, odds ratio 1.7, 95% confidence interval 1.1-2.6). Our study suggested astrong association between MIF gene -173G> C polymorphism and osteoporosis in aTurkish population.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
